At Bertram & Graf, L.L.C., we are passionate about holding pharmaceutical companies liable for manufacturing, producing, and marketing dangerous or defective drugs. Abilify, a drug used to treat mental disorders, has caused compulsive behaviors like gambling in countless users. The pharmaceutical companies knew of the risks of Abilify, and failed to warn doctors and patients. If you or a loved one have suffered compulsive behaviors as a result of taking Abilify, our Kansas City dangerous drug lawyers are here to help. We will gather evidence to build your case, and will represent you aggressively as you seek compensation for physical, mental, emotional, and financial damages.
Contact us today to get started with a free initial consultation.
Abilify is the brand name of the drug known as aripiprazole. An antipsychotic drug, it is used to treat mental disorders such as chronic depression, bipolar disorder, and schizophrenia. However, the drug has also been prescribed for off-label and unapproved uses, such as for dementia, obsessive-compulsive disorders, anxiety, and eating disorders.
Studies have shown that Abilify affects the impulse-control center of the brain. This means those who take Abilify may experience sudden, intense, and irresistable urges to do things they normally would not do. The most common destructive behavior patients experienced was compulsive gambling. Countless lawsuits have been filed against the manufacturers of Abilify for financial damages related to compulsive gambling.
Patients have also suffered:
Because of using Abilify, patients have suffered excessive weight gain, financial hardship, and other physical, mental, and emotional damages. Now, there are hundreds of lawsuits pending as they seek to regain money lost to gambling, compensation for emotional distress, and other types of compensation.
The manufacturer of Abilify, Otsuka Pharmaceutical, and the marketing company for Abilify, Bristol-Myers Squibb, are defendants in the Abilify lawsuits. They knowingly manufactured and sold the drug without warning doctors and consumers of the risks of compulsive behaviors. Now, they are being held liable for negligently producing a defective and dangerous drug.
Prior to 2016, there were no warnings about compulsive tendencies on the drug’s label. In 2016, the companies added a “pathological gambling” warning to the Postmarketing Experience section of the label in the U.S., but they made no effort to put clear warnings on the patient medication guide, which is the main source of information for doctors and patients. Pharmaceutical companies have a responsibility to provide adequate warnings of any harmful side effects that a drug could produce. Failure to do so for Abilify has resulted in immense suffering for thousands of patients and their families.
Pharmaceutical companies should never be allowed to put profits over the health of patients. If you or a loved one have suffered from compulsive gambling or other destructive behaviors as a result of using Abilify, you have the right to pursue compensation in a personal injury lawsuit. Bertram & Graf, L.L.C. is backed by a track record of success. Our Kansas City product liability lawyers will discuss your options, build your case, and aggressively uphold your right to compensation. Otsuka Pharmaceutical & Bristol-Myers Squibb must be held accountable for negligently producing and marketing Abilify without warning doctors and patients.
Ready to discuss your case with a member of our team? Contact our firm today for a free consultation.